MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹4.56 Cr | ₹3.25 Cr | ₹1.86 Cr | ₹2.11 Cr | ₹1.48 Cr |
What is the latest Long Term Provisions ratio of MARKSANS PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹4.56 Cr |
Mar2023 | ₹3.25 Cr |
Mar2022 | ₹1.86 Cr |
Mar2021 | ₹2.11 Cr |
Mar2020 | ₹1.48 Cr |
How is Long Term Provisions of MARKSANS PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹4.56 Cr | 40.19 | |
Mar2023 | ₹3.25 Cr | 75.22 | |
Mar2022 | ₹1.86 Cr | -12.08 | |
Mar2021 | ₹2.11 Cr | 43.12 | |
Mar2020 | ₹1.48 Cr | - |
Compare Long Term Provisions of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,459.2 Cr | -4.5% | -12.9% | 62.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹437,135.0 Cr | 2.6% | -1.1% | 38.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,074.0 Cr | -3.8% | -1.9% | 60.1% | Stock Analytics | |
CIPLA | ₹114,019.0 Cr | -2.4% | -5.2% | 10.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,192.0 Cr | -5.9% | -9.6% | 14.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,256.3 Cr | -3.9% | -0.3% | 40.6% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -4.5% |
-12.9% |
62.5% |
SENSEX | -0.6% |
-2.9% |
6.3% |
You may also like the below Video Courses